CNA2Subpathway: identification of dysregulated subpathway driven by copy number alterations in cancer

Abstract

Biological pathways reflect the key cellular mechanisms that dictate disease states, drug response and altered cellular function. The local areas of pathways are defined as subpathways (SPs), whose dysfunction has been reported to be associated with the occurrence and development of cancer. With the development of high-throughput sequencing technology, identifying dysfunctional SPs by using multi-omics data has become possible. Moreover, the SPs are not isolated in the biological system but interact with each other. Here, we propose a network-based calculated method, CNA2Subpathway, to identify dysfunctional SPs is driven by somatic copy number alterations (CNAs) in cancer through integrating pathway topology information, multi-omics data and SP crosstalk. This provides a novel way of SP analysis by using the SP interactions in the system biological level. Using data sets from breast cancer and head and neck cancer, we validate the effectiveness of CNA2Subpathway in identifying cancer-relevant SPs driven by the somatic CNAs, which are also shown to be associated with cancer immune and prognosis of patients. We further compare our results with five pathway or SP analysis methods based on CNA and gene expression data without considering SP crosstalk. With these analyses, we show that CNA2Subpathway could help to uncover dysfunctional SPs underlying cancer via the use of SP crosstalk. CNA2Subpathway is developed as an R-based tool, which is freely available on GitHub (https://github.com/hanjunwei-lab/CNA2Subpathway).

Colon Cancer-Related Genes Identification and Function Study Based on Single-Cell Multi-Omics Integration

“…High and low methylated CpG sites have been identified using the data of Illumina Human Methylation 450K (Naumov et al, 2013). The Wnt signaling pathway (Novellasdemunt et al, 2015;Sheng et al, 2021), Rap1 signaling (Zhang et al, 2017), and many other signaling pathways have been confirmed to have an effect on colon cancer, at the same time, GDNF (Zhong et al, 2018), BMP3 (Park et al, 2016), and a few other genes have been regarded as the signs of malignant colon cancer, while NEU1 (Uemura et al, 2009) as well as others suppress metastasis.…”

Identification of Somatic Mutation-Driven Immune Cells by Integrating Genomic and Transcriptome Data

“…Recently, a number of calculated methods have been developed to identify dysregulated genes and pathways in cancer using molecular omics data (genome or transcriptome) ( Cheng et al, 2019 ; Han et al, 2020 ; Sheng et al, 2021 ). Moreover, some methods were proposed to prioritize cancer candidate drugs and prognostic markers ( Han et al, 2018 , 2021 ; Di et al, 2019 ).…”

AOPM: Application of Antioxidant Protein Classification Model in Predicting the Composition of Antioxidant Drugs

“…Feature selection obtains the most effective feature subset for classification and recognition of the many features ( Wang et al, 2010 ; Mo et al, 2020 ; Sheng et al, 2021 ; Wu et al, 2021 ). That is, it captures a set of “small but precise” classification features with a small probability of error.…”